Search Results for 'biosensors'

NUI Galway researchers and company partners have been awarded over €10.3 million in Disruptive Technologies Innovation Fund (DTIF). The Disruptive Technologies Innovation Fund was established under Project Ireland 2040 and is run by the Department of Business, Enterprise and Innovation with administrative support from Enterprise Ireland.

Researchers from the National University of Ireland Galway (NUI Galway), Massachusetts Institute of Technology and AMBER, the SFI Research Centre for Advanced Materials and BioEngineering Research have today (Thursday, 29 August) announced a significant breakthrough in soft robotics which could help patients requiring in-situ (implanted) medical devices such as breast implants, pacemakers, neural probes, glucose biosensors and drug and cell delivery devices.

Researchers from the National University of Ireland Galway (NUI Galway) have today (Thursday) revealed a significant breakthrough in soft robotics which could help patients requiring implanted medical devices such as breast implants, pacemakers, neural probes, glucose biosensors and drug and cell delivery devices.